Instil Bio Stock Net Income

TIL Stock  USD 24.76  1.40  5.99%   
Instil Bio fundamentals help investors to digest information that contributes to Instil Bio's financial success or failures. It also enables traders to predict the movement of Instil Stock. The fundamental analysis module provides a way to measure Instil Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Instil Bio stock.
Last ReportedProjected for Next Year
Net Loss-197 M-206.9 M
Net Loss-141.1 M-134.1 M
Net Loss-156.1 M-163.9 M
Net Loss(24.00)(25.20)
Net Income Per E B T 1.14  1.10 
The value of Net Loss is expected to slide to about (206.9 M). Net Loss is expected to rise to about (134.1 M) this year.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Instil Bio Company Net Income Analysis

Instil Bio's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

More About Net Income | All Equity Analysis

Current Instil Bio Net Income

    
  (156.09 M)  
Most of Instil Bio's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Instil Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Instil Net Income Driver Correlations

Understanding the fundamental principles of building solid financial models for Instil Bio is extremely important. It helps to project a fair market value of Instil Stock properly, considering its historical fundamentals such as Net Income. Since Instil Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Instil Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Instil Bio's interrelated accounts and indicators.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Instil Accumulated Other Comprehensive Income

Accumulated Other Comprehensive Income

(365,400)

The company's current value of Accumulated Other Comprehensive Income is estimated at (365,400)
Based on the recorded statements, Instil Bio reported net income of (156.09 Million). This is 145.74% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 127.34% higher than that of the company.

Instil Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Instil Bio's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Instil Bio could also be used in its relative valuation, which is a method of valuing Instil Bio by comparing valuation metrics of similar companies.
Instil Bio is currently under evaluation in net income category among its peers.

Instil Bio ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Instil Bio's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Instil Bio's managers, analysts, and investors.
Environmental
Governance
Social

Instil Bio Institutional Holders

Institutional Holdings refers to the ownership stake in Instil Bio that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Instil Bio's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Instil Bio's value.
Shares
Geode Capital Management, Llc2024-06-30
36.4 K
Millennium Management Llc2024-06-30
31.6 K
Two Sigma Advisers, Llc2024-06-30
28.1 K
Two Sigma Investments Llc2024-06-30
23.8 K
State Street Corp2024-06-30
12.2 K
Morgan Stanley - Brokerage Accounts2024-06-30
10.1 K
Dimensional Fund Advisors, Inc.2024-09-30
10 K
Northern Trust Corp2024-09-30
7.1 K
Omers Administration Corp2024-09-30
3.8 K
Vivo Capital, Llc2024-09-30
624.3 K
Cpmg Inc2024-06-30
410.9 K

Instil Fundamentals

About Instil Bio Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Instil Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Instil Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Instil Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Instil Bio is a strong investment it is important to analyze Instil Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Instil Bio's future performance. For an informed investment choice regarding Instil Stock, refer to the following important reports:
Check out Instil Bio Piotroski F Score and Instil Bio Altman Z Score analysis.
For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide.
You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Instil Bio. If investors know Instil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Instil Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(11.56)
Return On Assets
(0.12)
Return On Equity
(0.49)
The market value of Instil Bio is measured differently than its book value, which is the value of Instil that is recorded on the company's balance sheet. Investors also form their own opinion of Instil Bio's value that differs from its market value or its book value, called intrinsic value, which is Instil Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Instil Bio's market value can be influenced by many factors that don't directly affect Instil Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Instil Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Instil Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Instil Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.